The telomerase activating potency of TA-65® has been independently proven in rigorous tests by Geron and Sierra Sciences, two biotech companies specializing in telomere biology.
Furthermore the fact that TA-65® activates telomerase and lenghtens telomeres has been validated by several clinical studies.
In 2005 the results of a study show the experiences of real people with TA-65®. This was a double-blind, placebo-controlled study, interpreted by Ph.D., Dr. Jochen Kumm from Stanford University.
In March 2016 the first randomized, double blind, placebo controlled study to show telomeres getting longer in humans confirms that TA-65® can lengthen telomeres in a statistically and possibly clinically significant manner. Published in Rejuvenation Research PMID 26950204